GoldenGolden
Advanced Search

Evelo Biosciences

Evelo Biosciences is a biomedical engineering company.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

July 13, 2017
Evelo Biosciences raises a $50,000,000 series B round from Flagship Pioneering.
July 2017
Evelo Biosciences raises a $50,000,000 series B round from Celgene, Flagship Pioneering and Mayo Clinic.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
July 8, 2021
BioSpace
PlateletBio Names Derek Adams, Ph.D., as Chief Operating Officer - read this article along with other careers information, tips and advice on BioSpace
BioSpace
June 1, 2021
BioSpace
Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced the appointment of Mark Plinio as Chief Commercial Officer, effective June 14, 2021.
BioSpace
April 20, 2021
BioSpace
-Evelo presents late-breaking abstract at the International Society of Atopic Dermatitis Annual Meeting- -Meaningful improvements over placebo on clinical scores, including new data released on key IGA endpoints- -Initiation of Phase 2 trial of EDP1815 in atopic dermatitis expected in 3Q 2021-
Alex Keown
April 16, 2021
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
BioSpace
April 15, 2021
BioSpace
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointments of Luca Scavo as Chief Financial Officer (CFO), effective June 1, 2021, and Julie H. McHugh to its Board of Directors, effective immediately.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.